Evidence map›Paper›PMID 31610451›Full record

ArticleThe International journal on drug policy2019

Adulterants and altruism: A qualitative investigation of "drug checkers" in North America.

Joseph J Palamar, Patricia Acosta, Rachel Sutherland, Michele G Shedlin, Monica J Barratt

Abstract read
In one paragraph

Article in The International journal on drug policy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Peer Support and Overdose Prevention Responses: A Systematic 'State-of-the-Art' Review.International journal of environmental research and public health · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Joseph J PalamarDepartment of Population Health, New York University School of Medicine, 180 Madison Avenue, Room 1752, New York, NY 10016, USA; Center for Drug Use and HIV/HCV Research, NYU College of Global Public Health, New York, NY, USA. Electronic address: joseph.palamar@nyu.edu.
Patricia AcostaDepartment of Population Health, New York University School of Medicine, 180 Madison Avenue, Room 1752, New York, NY 10016, USA.
Rachel SutherlandNational Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia.
Michele G ShedlinCenter for Drug Use and HIV/HCV Research, NYU College of Global Public Health, New York, NY, USA.
Monica J BarrattSocial and Global Studies Centre, RMIT University, Melbourne, Australia; National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia.

Funding

Transdisciplinary Theoretical Svnthesis and Development CoreP30DA011041 · NIDA · NEW YORK UNIVERSITY · PI Holly Hagan, Courtney McKnight · 1998 to 2026
$38.9M
Drug use among nightclub and dance festival attendees in New York CityR01DA044207 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PALAMAR, JOSEPH J · 2018 to 2021
$1.5M
Development of a Rapid Survey to Detect Use of New and Emerging DrugsK01DA038800 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PALAMAR, JOSEPH J · 2015 to 2019
$879k
NIDA NIH HHS K01 DA038800NIDA NIH HHS P30 DA011041NIDA NIH HHS R01 DA044207
6 · The paper itself

Abstract

background"Drug checking" has become a common harm reduction method used to test illicit substances, such as ecstasy, for purity and/or the presence of adulterants. Formal drug-checking services have been operating for decades, and the use of personal reagent test kits appears to be relatively common; however, little attention has been devoted to understanding the role and broader experiences of 'drug-checkers' (i.e., people who test their own and/or other people's substances). As such, it remains unknown who is engaging in this practice, their motivations for drug-checking, and what barriers they may experience. We addressed this research gap by interviewing people who check drugs about their experiences, with a goal of better understanding drug checking practices.

methodsWe conducted in-depth interviews with 32 adults in North America who reported testing drugs. Coding was conducted in an inductive manner and thematic analysis was used to identify relevant themes.

resultsOver half (56.2%) of our sample was affiliated with a drug checking organization. Among non-affiliated checkers (43.8%), the majority (57.1%) tested for friends, 21.4% tested only for themselves, and 21.4% were people who sold drugs and tested for their clients. Motivations were driven largely by altruism, described by checkers as wanting to protect their peers from exposure to adulterants. People interviewed who sold drugs were altruistic in the same manner. Barriers to checking-particularly at nightclubs and festivals-included perceived illegality of test kits and denied approval to test drugs at venues, although many checkers circumvented this barrier by checking drugs without such approval.

conclusionsDrug checkers in North America seek to educate people who use drugs about the risk of exposure to unexpected substance types, but they face various barriers. Policy change could help ensure that these potentially life-saving services can be provided without fear of fines and/or criminal prosecution.

Indexed as

AltruismHarm ReductionAdolescentAdultDrug ContaminationDrug UsersFemaleHumansIllicit DrugsInterviews as TopicMaleMotivationNorth AmericaYoung AdultIllicit DrugsAltruismDrug checkingEcstasyHarm reductionNew psychoactive substances

Identifiers

PMID31610451
PMCPMC6893085

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.